FNKLX | VIVIX | FNKLX / VIVIX | |
Total Expense Ratio | 0.00 | 0.04 | - |
Annual Report Gross Expense Ratio | 0.00 | 0.04 | - |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 6.707 | 6.533 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.3B | 196B | 7% |
Annual Yield % from dividends | 2.38 | 2.19 | 109% |
Returns for 1 year | 5.49 | 7.91 | 69% |
Returns for 3 years | 11.94 | 25.93 | 46% |
Returns for 5 years | 45.50 | 68.54 | 66% |
Returns for 10 years | 52.95 | 114.61 | 46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 22.88 | 0.48 | +2.14% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
BKIV | 38.65 | 0.62 | +1.62% |
BNY Mellon Innovators ETF | |||
HYEM | 19.99 | -0.01 | -0.05% |
VanEck EM High Yield Bond ETF | |||
KNOV | 26.26 | -0.06 | -0.23% |
Innovator U.S. Small Cp Pwr Buf ETF -Nov | |||
JPC | 8.03 | -0.07 | -0.86% |
Nuveen Preferred & Income Opportunities Fund |